Vitae Pharmaceuticals (VTAE) Misses Q1 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. NVT
8. AAPL
9. LITE
10. BP

Go back to Vitae Pharmaceuticals (VTAE) Misses Q1 EPS by 12c

Vitae Pharmaceuticals Reports First Quarter 2015 Operating and Financial Results

May 12, 2015 4:05 PM EDT

Multiple impending 2Q inflection points supported by enhanced cash position

Conference call scheduled for 4:30 p.m. EDT today

FORT WASHINGTON, Pa., May 12, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq: VTAE), a clinical-stage biotechnology company developing a robust and growing portfolio generated by its proprietary structure-based drug discovery platform, reported today its operating and financial results for the first quarter ended March 31, 2015.

"During the first quarter, we continued to execute on our plans to deliver important near-term value drivers for shareholders that we hope will ultimately... More